UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date
of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
| (Address of Principal Executive Offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01 | Regulation FD Disclosure. |
On September 23, 2025, Lifeloc Technologies, Inc. released a press release titled “Lifeloc to Present at Emerging Growth Conference on September 25, 2025”.
A copy of the press release is furnished herewith as Exhibit 99.1. Neither the press release nor the contents of any websites linked therein shall be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall be deemed incorporated by reference herein or in any other filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit No. | Description |
| 10.1 | Press Release, dated September 23, 2025, issued by the Company |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: September 23, 2025 | LIFELOC TECHNOLOGIES, INC. | |
| By: | /s/ Wayne R. Willkomm | |
Wayne R. Willkomm, PhD. President and Chief Executive Officer | ||
Exhibit 99.1
Lifeloc to Present at Emerging Growth Conference on September 25, 2025
WHEAT RIDGE, Colo., September 23, 2025 – Lifeloc Technologies, Inc. (OTC: LCTC), a U.S.-based manufacturer of precision breath alcohol and drug detection devices, announced today that it will present at the Emerging Growth Conference on Thursday, September 25, 2025.
This live, interactive virtual event will feature a presentation by Dr. Wayne Willkomm, Lifeloc’s Chief Executive Officer. Dr. Willkomm will provide an overview of Lifeloc’s current operations and share an update on the SpinDetect™ centrifugal drug analyzer, the Company’s next-generation analyzer currently under development.
Following the presentation, Dr. Willkomm will engage in a Q&A session with conference attendees. Questions may be submitted in advance to [email protected] or asked live during the event.
Emerging Growth Conference Details
| · | Date: Thursday, September 25, 2025 |
| · | Time: 2:20 PM Eastern Daylight Time |
| · | Webcast Registration: Click here to register |
A recording of the webcast will be made available after the event on both the Emerging Growth website and its YouTube channel: YouTube.com/EmergingGrowthConference. A direct link will be shared by Lifeloc once available.
Lifeloc is developing the SpinDetect™ centrifugal drug analyzer, a compact, microfluidic-based drug screening platform intended to meet the growing global demand for fast, portable drug testing solutions.
About Lifeloc Technologies
Lifeloc Technologies, Inc. (OTCID: LCTC) is a trusted U.S. manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections and International customers. Lifeloc stock trades over-the-counter under the symbol LCTC. We are a fully reporting Company with our SEC filings available on our web site, www.lifeloc.com/investor.
Forward Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. All forward-looking statements expressed or implied in this press release, including statements about our strategies, performance, expectations about new and existing products, market demand, economic conditions, acceptance of new and existing products, technologies and opportunities, market size and growth, market liquidity for our shares, and return on investments in products and market, are based on information available to us on the date of this document, and we assume no obligation to update such forward-looking statements. Investors are strongly encouraged to review the section titled “Risk Factors” in our SEC filings.
SpinDetec™ is a trademark of Lifeloc Technologies, Inc.
Amy Evans
Lifeloc Technologies, Inc.
http://www.lifeloc.com
(303) 431-9500